Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Chemotherapy-induced Neutropenia”

112 trials

Showing 20 of 112 results

Testing effectiveness (Phase 2)WithdrawnNCT00003407
What this trial is testing

Amifostine & High-Dose Combination Chemotherapy in Treating Patients With Acute ML or CML

Who this might be right for
Drug/Agent Toxicity by Tissue/OrganLeukemiaMyelodysplastic Syndromes+1 more
Rush University Medical Center
Testing effectiveness (Phase 2)Ended earlyNCT03301597
What this trial is testing

NLA101 in Adults Receiving High Dose Chemotherapy for AML

Who this might be right for
Leukemia, Myeloid, Acute
Nohla Therapeutics, Inc. 146
Testing effectiveness (Phase 2)Study completedNCT03314805
What this trial is testing

PG2 Breast Cancer Evaluation in Adjuvant Medicine Study

Who this might be right for
Cancer-related FatigueNeutropenia, Malignant
PhytoHealth Corporation 67
Large-scale testing (Phase 3)Study completedNCT02251977
What this trial is testing

Effect of GM1 in Prevention of Oxaliplatin Induced Neurotoxicity in Stage II/III Colorectal Cancer

Who this might be right for
Colorectal CancerChemotherapy-induced Neutropenia
Yuhong Li 196
Testing effectiveness (Phase 2)Study completedNCT00138736
What this trial is testing

Study on Mannan Binding Lectin (MBL) Substitution in MBL-Deficient Children With Chemotherapy-Induced Neutropenia

Who this might be right for
MBL-DeficientNeutropenia
Prothya Biosolutions 12
Post-approval studies (Phase 4)Looking for participantsNCT05874401
What this trial is testing

Trilaciclib vs Placebo in Patients With Extensive Stage Small Cell Lung Cancer (ES-SCLC) Receiving Topotecan

Who this might be right for
Extensive-stage Small-cell Lung Cancer
Pharmacosmos A/S 302
Post-approval studies (Phase 4)Looking for participantsNCT06616571
What this trial is testing

Compare the Efficacy and Safety of QL0605 Injections at Different Timepoints

Who this might be right for
Chemotherapy-Induced Febrile Neutropenia
Qilu Pharmaceutical Co., Ltd. 336
Large-scale testing (Phase 3)Study completedNCT04554056
What this trial is testing

Trial to Compare the Efficacy and Safety Of MW05 and PEG-rhG-CSF

Who this might be right for
Breast Cancer Female
Mabwell (Shanghai) Bioscience Co., Ltd. 586
Post-approval studies (Phase 4)Study completedNCT01107756
What this trial is testing

A Clinical Trial of Patients With Solid Tumours Receiving Granulocyte Colony Stimulating Factor as Primary Prophylaxis for Chemotherapy-induced Neutropenia, in a Docetaxel Based Regimen

Who this might be right for
Neoplasms (no Otherwise Specified)
Sanofi 403
Large-scale testing (Phase 3)Study completedNCT02953340
What this trial is testing

SPI-2012 vs Pegfilgrastim in Management of Neutropenia in Breast Cancer Participants With Docetaxel and Cyclophosphamide

Who this might be right for
NeutropeniaBreast Cancer
Spectrum Pharmaceuticals, Inc 237
Early research (Phase 1)Study completedNCT02643901
What this trial is testing

Tolerability and Pharmacokinetics(PK)/Pharmacodynamics(PD) Study of GW003 in Healthy Subjects

Who this might be right for
Chemotherapy-induced Neutropenia
Jiangsu T-Mab Biopharma Co.,Ltd 26
Large-scale testing (Phase 3)Study completedNCT00002719
What this trial is testing

Combination Chemotherapy With or Without G-CSF in Treating Older Patients With Acute Myeloid Leukemia

Who this might be right for
LeukemiaNeutropenia
European Organisation for Research and Treatment of Cancer - EORTC 500
Large-scale testing (Phase 3)Study completedNCT03102606
What this trial is testing

Plinabulin vs. Pegfilgrastim in Patients With Solid Tumors Receiving Docetaxel Myelosuppressive Chemotherapy Phase 3

Who this might be right for
Chemotherapy-induced Neutropenia
BeyondSpring Pharmaceuticals Inc. 105
Early research (Phase 1)Study completedNCT03246009
What this trial is testing

Fusion Protein rHSA/GCSFclinical Study on Breast Cancer Patients

Who this might be right for
Chemotherapy-induced NeutropeniaCancer, Breast
Tianjin SinoBiotech Ltd. 24
Large-scale testing (Phase 3)Not Yet RecruitingNCT07483736
What this trial is testing

Efficacy of an Empirical Treatment With Amoxicillin-clavulanate (AC) Compared to the Combination Amoxicillin-clavulanate and Ciprofloxacin (AC+C) in the Outpatient Care of Chemotherapy-induced Fever in Adult Haematology Patients.

Who this might be right for
C15.378
Versailles Hospital 1,526
Testing effectiveness (Phase 2)Study completedNCT00497809
What this trial is testing

Safety and Efficacy Study of GCSF Therapy to Treat Patients at High Risk for Chemotherapy Induced Severe Neutropenia

Who this might be right for
Breast CancerNeutropenia
AviGenics 189
Not applicableStudy completedNCT02178475
What this trial is testing

Prospective Observational Study of Febrile Neutropenia (FN) and Pegfilgrastim Primary Prophylaxis in Breast Cancer and Non-Hodgkin's Lymphoma Patients Receiving High (>20%) FN-risk Chemotherapy

Who this might be right for
Chemotherapy-induced Febrile Neutropenia
Amgen 943
Not applicableStudy completedNCT04460079
What this trial is testing

Safety and Effectiveness Assessment of PeGagen® (Pegfilgrastim) in the Prevention of Chemotherapy-induced FN

Who this might be right for
Chemotherapy-induced Neutropenia
Cinnagen 654
Post-approval studies (Phase 4)Study completedNCT02816164
What this trial is testing

Compare Administration Schedules of G-CSF (Filgrastim) for Primary Prophylaxis of Febrile Neutropenia

Who this might be right for
Early Stage Breast Cancer
Ottawa Hospital Research Institute 324
Testing effectiveness (Phase 2)Study completedNCT02005458
What this trial is testing

Safety and Efficacy of YPEG-rhG-CSF in Cancer Patients Receiving Chemotherapy

Who this might be right for
Non Small Cell Lung CancerBreast Cancer
Xiamen Amoytop Biotech Co., Ltd. 80
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation